Half-lives of PFOS, PFHxS and PFOA after end of exposure to contaminated drinking water

被引:535
作者
Li, Ying [1 ]
Fletcher, Tony [2 ]
Mucs, Daniel [3 ]
Scott, Kristin [4 ]
Lindh, Christian H. [4 ]
Tallving, Pia [4 ]
Jakobsson, Kristina [1 ,4 ]
机构
[1] Univ Gothenburg, Dept Publ Hlth & Community Med, Div Occupat & Environm Med, Gothenburg, Sweden
[2] London Sch Hyg & Trop Med, Dept Social & Environm Hlth Res, London, England
[3] Karolinska Inst, Swetox, Unit Toxicol Sci Sodertalje, Stockholm, Sweden
[4] Lund Univ, Dept Lab Med, Div Occupat & Environm Med, Lund, Sweden
基金
瑞典研究理事会;
关键词
PERFLUOROALKYL ACIDS; SERUM CONCENTRATIONS; ELIMINATION; URINE; LIFE;
D O I
10.1136/oemed-2017-104651
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background Municipal drinking water contaminated with perfluorinated alkyl acids had been distributed to one-third of households in Ronneby, Sweden. The source was firefighting foam used in a nearby airfield since the mid-1980s. Clean water was provided from 16 December 2013. Objective To determine the rates of decline in serum perfluorohexane sulfonate (PFHxS), perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA), and their corresponding half-lives. Methods Up to seven blood samples were collected between June 2014 and September 2016 from 106 participants (age 4-84 years, 53% female). Results Median initial serum concentrations were PFHxS, 277 ng/mL (range 12-1660); PFOS, 345 ng/mL (range 24-1500); and PFOA, 18 ng/mL (range 2,4-92). The covariate-adjusted average rates of decrease in serum were PFHxS, 13% per year (95% CI 12% to 15%); PFOS, 20% per year (95% CI 19% to 22%); and PFOA, 26% per year (95% CI 24% to 28%). The observed data are consistent with a first-order elimination model. The mean estimated half-life was 5.3 years (95% CI 4.6 to 6.0) for PFHxS, 3,4 years (95% CI 3,1 to 3,7) for PFOS and 2.7 years (95% CI 2.5 to 2.9) for PFOA. The interindividual variation of half-life was around threefold when comparing the 5th and 95th percentiles. There was a marked sex difference with more rapid elimination in women for PFHxS and PFOS, but only marginally for PFOA. Conclusions The estimated half-life for PFHxS was considerably longer than for PFOS and PFOA, For PFHxS and PFOS, the average half-life is shorter than the previously published estimates. For PFOA the half-life is in line with the range of published estimates.
引用
收藏
页码:46 / 51
页数:6
相关论文
共 22 条
  • [11] Blood serum concentrations of perfluorinated compounds in men from Greenlandic Inuit and European populations
    Lindh, Christian H.
    Rylander, Lars
    Toft, Gunnar
    Axmon, Anna
    Rignell-Hydbom, Anna
    Giwercman, Aleksander
    Pedersen, Henning S.
    Goalczyk, Katarzyna
    Ludwicki, Jan K.
    Zvyezday, Valentyna
    Vermeulen, Roel
    Lenters, Virissa
    Heederik, Dick
    Bonde, Jens Peter
    Jonsson, Bo A. G.
    [J]. CHEMOSPHERE, 2012, 88 (11) : 1269 - 1275
  • [12] Evaluation and prediction of pharmacokinetics of PFOA and PFOS in the monkey and human using a PBPK model
    Loccisano, Anne E.
    Campbell, Jerry L., Jr.
    Andersen, Melvin E.
    Clewell, Harvey J., III
    [J]. REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2011, 59 (01) : 157 - 175
  • [13] MiraIles-Marco A, 2015, ENVIRON INT, V77, P148, DOI [10.1016/j.envint.2015., 10.1016/j.envint.2015.02.002]
  • [14] Half-life of serum elimination of perfluorooctanesulfonate, perfluorohexanesulfonate, and perfluorooctanoate in retired fluorochemical production workers
    Olsen, Geary W.
    Burris, Jean M.
    Ehresman, David J.
    Froehlich, John W.
    Seacat, Andrew M.
    Butenhoff, John L.
    Zobel, Larry R.
    [J]. ENVIRONMENTAL HEALTH PERSPECTIVES, 2007, 115 (09) : 1298 - 1305
  • [15] Temporal Trends of Perfluoroalkyl Concentrations in American Red Cross Adult Blood Donors, 2000-2010
    Olsen, Geary W.
    Lange, Cleston C.
    Ellefson, Mark E.
    Mair, David C.
    Church, Timothy R.
    Goldberg, Corinne L.
    Herron, Ross M.
    Medhdizadehkashi, Zahra
    Nobiletti, John B.
    Rios, Jorge A.
    Reagen, William K.
    Zobel, Larry R.
    [J]. ENVIRONMENTAL SCIENCE & TECHNOLOGY, 2012, 46 (11) : 6330 - 6338
  • [16] A comparison of the pharmacokinetics of perfluorobutanesulfonate (PFBS) in rats, monkeys, and humans
    Olsen, Geary W.
    Chang, Shu-Ching
    Noker, Patricia E.
    Gorman, Gregory S.
    Ehresman, David J.
    Lieder, Paul H.
    Butenhoff, John L.
    [J]. TOXICOLOGY, 2009, 256 (1-2) : 65 - 74
  • [17] Robinson GK., 1991, Statistical Science, V6, P15, DOI [10.1214/ss/1177011926, DOI 10.1214/SS/1177011926]
  • [18] Tracking the Pathways of Human Exposure to Perfluorocarboxylates
    Vestergren, Robin
    Cousins, Ian T.
    [J]. ENVIRONMENTAL SCIENCE & TECHNOLOGY, 2009, 43 (15) : 5565 - 5575
  • [19] Differences in the isomer composition of perfluoroctanesulfonyl (PFOS) derivatives
    Vyas, Sandhya M.
    Kania-Korwel, Izabela
    Lehmler, Hans-Joachim
    [J]. JOURNAL OF ENVIRONMENTAL SCIENCE AND HEALTH PART A-TOXIC/HAZARDOUS SUBSTANCES & ENVIRONMENTAL ENGINEERING, 2007, 42 (03): : 249 - 255
  • [20] Enhanced Elimination of Perfluorooctane Sulfonic Acid by Menstruating Women: Evidence from Population-Based Pharmacokinetic Modeling
    Wong, Fiona
    MacLeod, Matthew
    Mueller, Jochen F.
    Cousins, Ian T.
    [J]. ENVIRONMENTAL SCIENCE & TECHNOLOGY, 2014, 48 (15) : 8807 - 8814